Management bought back $426M of stock in the same quarter core revenue shrank 9%.
Thesis: Keysight is a quality trap. They are executing perfectly—expanding margins to 66% and generating robust free cash flow—in a shrinking market. The 'AI' tailwind is currently just a wireline manufacturing niche ($1.3B backlog vs $1.3B quarterly burn means coverage is thinning). The structural position is dominant, but the cyclical position is toxic. You don't pay a growth multiple for a company managing a decline, no matter how efficiently they do it.
Verdict: AVOID — Conviction: HIGH
Catalyst: Q2 order book. If the 'typical seasonal increase' fails to materialize or is purely inorganic, the growth narrative breaks.
Key Risk: Backlog quality. Management admitted 'delays in the fabs' are pushing delivery timelines. If these pushouts turn into cancellations, the $2.3B floor collapses.
The Tell: The CFO's blunt math on Q1 guidance: '1245 less 60 million gets you to 1185 for core key site... we expect the sequential decline this year to be a little bit larger than historical average.' He explicitly stripped away the acquisition veneer to reveal the organic deterioration.
Friction Level: MODERATE_FRICTION — The durability of the 'second half recovery' narrative. Bulls see a pause before AI growth; Bears see structural normalization that backlog can no longer mask.
Report not found
The report data is no longer available. Please return to the archive.